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INTRODUCTION 
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INTRODUCTION 
 
 
 Diabetes and Pleuropulmonary Infections – A tale of two troubles. 
 
 DM is a chronic metabolic disorder seen in 5 to 10 % of the elderly population 
(1) .At the turn of the century many diabetic patients died of overwhelming infections.  
The introduction of insulin dramatically altered this situation and today non-
communicable diseases are the major cause of death in diabetic patients.  However 
infections in diabetics still poses a great challenge to physicians.  It is a wake up call for 
all Clinicians and researchers to gear up to meet the challenge of the brewing double 
trouble. 
 
 Clinicians have generally believed that diabetics are more susceptible to 
infections and that infections are generally more severe in diabetics than they are in 
non-diabetics.  Pulmonary infections (including PTB as well as other bacterial 
pneumonia) accounts for about 31% of infections in DM (2). Infections continue to be 
an important cause of concern in diabetics especially in developing countries like India 
and there has been a scarcity of controlled studies (3)  that have conclusively shown 
that certain infections are more common in diabetics as compared to non-diabetics. We 
conducted a prospective study to analyse the spectrum of pleuropulmonary infections in 
Diabetes Mellitus. 
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AIM 
 
 
The  aim  of  our  study  is  to  analyse  the  clinical,  radiological  and 
microbiological  aspects  of  Pleuropulmonary  Infections  in  Diabetes  Mellitus. 
 
 
 
STUDY  DESIGN: 
 
Prospective  study. 
 
 
 
This  study  was  examined  and  approved  by  the  Ethical  Committee of   the 
 
institution. 
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REVIEW OF LITERATURE 
 
 
 Diabetes is one of the oldest diseases known to mankind.  The eber papyrus of 
1500BC mentions its symptoms and suggests treatment.  In the same way infections 
related to diabetes are also known for long.  The fateful association of diabetes mellitus 
and tuberculosis has been known for nearly one thousand years.  At the turn of the 
century many diabetic patients still represent an important issue.  Infection tends to 
occur at greater frequency and severity in diabetic patients than in non-diabetic.  The 
occurrence of infection in a diabetic patient perpetuates a vicious cycle in which 
infection results in uncontrolled hyperglycemia which in turn causes further aggravation 
of infections. 
 
Diabetics are more prone for infections as compared to normal.  Uncontrolled 
diabetics rapidly promotes infection.  There is a typical association of infection with 
diabetes, as sugar is a good media for rapid and abundant growth of organisms and at 
the same time infection itself distorts the blood sugar levels and may precipitate Keto 
acidosis.  Such infections are responsible for complications and morbidity more 
frequently than would be anticipated in normal individuals.  However now-a-days due  
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to improvement in the greater wealth and better understating of diabetes  and with the 
development of most effective diagnostic techniques, earlier intervention with newer  
human insulins as well as availability of broad spectrum antibiotics with better 
tolerability have made the results  more favourable and hence the death rates due to 
infections had gone down from 17.6% in pre-insulin era to 8.5% in insulin era.  Let us 
hope still some better data will come out in recent future. 
 
HYPERGLYCEMIA AND IMMUNE SYSTEM: 
 
It is said in diabetics there are certain factors, which play part in this direction.  
Increased susceptibility in Type 1 diabetic do play role.  The impairment of wide range 
of functions in neutrophils and macrophages including chemotaxis and adherence 
,phagocytosis and intracellular killing of microorganisms is brought by hyperglycemia.  
In diabetes the movement of phagocytic cells may be generally impaired. 
 
 The W.H.O. has included diabetes in its classification of secondary 
immunodeficiency diseases. The development of secondary immunodeficiency seems 
to be alterations involving at generally including polymorphonuclear granulocytes  
and/or  lymphocytic  subsets  activity. 
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Polymorphonuclear granulocytes represent the host’s first defense barrier against 
bacterial agents.  Alteration in chemotaxis, phagocytosis , immunoglobulin production  
and complement functions do occur in diabetic patients (11). Polymorphonuclear 
granulocytes cells from diabetics have a reduced chemotaxis especially when the 
diabetes is poorly controlled.  There are two stages of phagocytosis adhesion and 
ingestion of microorganisms into intracytoplasmic vacuole.  An increase in sialidase 
enzyme secretion together with corresponding reduction in cell membrane sialic acid 
may pay part along with defective Lactin receptors losing their capacity to recognize 
target and fail to initiate phagocytosis.  The critical step of intracellular killing is 
mediated by the release of toxic free radicals, super oxides and hydrogen peroxide.  
This “respiratory bust” which is impaired in diabetics correlates with intracellular 
killing (24).  This whole process is dependent on NADPH. 
 
 The NADPH is normally generated by the metabolism of glucose through HMP 
shunt and in diabetics more glucose enters the phagocytes and is metabolized by polyol 
pathway.  Aldose  reductase, the rate limiting enzyme of this process requires NADPH 
and this is consumed when flux through polyol pathway increase.  This competition for 
NADPH is thought to account for the reduction in the respiratory bust and in 
intracellular killing. 
             6 
The metabolic disturbances associated with diabetes are probably important in 
impairing the function of polymorphonuclear cells. Once phagosome and lysosome  
function has taken place, killing is carried out by the lysosmal enzymes.  A decrease in 
the killing capacity of polymorphonuclear granulocytes associated with high blood 
sugar may come to normalization within 48 hours after correction of blood sugar levels. 
 
 Several immunoglobulin levels IG G and IG A have been reported to be reduced 
in diabetics as compared to normal.  As well as significant reduction in the quantity and 
functional activity of complement component may occur in diabetic patients.  Above all 
these local factors like underlying susceptibility to infection, vascular disease, nerve 
damage and increase in blood sugar may aggravate the process.  This may call upon 
decrease circulation, hypoxia and reduction in absorption of antibiotics and 
proliferation of bacteria. 
 
In type I diabetes or IDDM, genetic predisposition to infections also plays a part.  
Along with all above factors, which are abnormalities of phagocyte functions 
mobilization & chemotaxis, adherence, phagocytosis, and intracellular killing with 
bactericidal activities, micro vascular circulation abnormality may result in decreased 
tissue perfusion.  Hyperglycemia per say reduces oxidative killing capacity because of  
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increased glucose metabolism through polyol pathway depleting NADPH, which is 
necessary for generation of superoxide free radicals. 
 
In type 1 DM, there is alteration in some lymphocytes subpopulations, a 
reduction in T lymphocytes and specifically in the number of CD4 phenotype (25) and 
reduction in CD4/CD8 ratio, serum immunoglobulin levels IgG and IgA have been 
reported to be reduced in diabetics compared to normal.  As well as significant 
reduction in the quantity and functional activity of complements may occur in diabetics 
patients.  An underlying susceptibility of target tissues due to hyperglycemia, vascular 
disease and nerve damage is proved with the relative tissue hypoxia may cause 
proneness to infections.  A reduction in antibiotic absorption due to microangiopathy 
may lead to persistence of infections.  About 25% of IDDM subject have this. 
CHANGES IN MICROCIRCULATION: 
The presence of healthy microcirculation is essential to certain infectious insults.  
Alteration in the function of capillary endothelium, the rigidity of red blood corpuscles 
and changes in the oxygen dissociation curve that occur as a result of chronic 
hyperglycemia are factors which affect the host’s ability to combat infections.  It is 
therefore no surprise that patients with longstanding diabetes with complications are at 
a much greater risk of infections than non-diabetics or diabetes without complications.  
The reduced oxygen supply to tissue as a result of micro vascular changes predisposes  
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them to infections by anaerobic microorganisms which grow best under such conditions 
(26,27). 
 
OTHER REASONS: 
 
 Diabetic gastro paresis may increase the risk of aspiration (28).  Some 
medications may impair host defence: Calcium channel blockers may impair phagocyte 
function, whereas digoxin may decrease clearance of pneumococci from the lower 
respiratory tree.  Abnormalities in ciliary motility are also important.  Pneumonia, PT, 
fungal infections and parasitic infections have a different course in diabetics than in 
general population (24). 
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To sum up the list of defects in diabetics’ immunologic make up and physiologic 
pulmonary functions are as follows: (30) 
 
Immunologic abnormalities in 
diabetics. 
Pulmonary Anatomical & 
physiologic disturbances in 
diabetics. 
Abnormal chemotaxis, adherences 
phagocytosis and microbicidal 
function of polymorphonuclear 
leucocytes. 
Diminished bronchial reactivity. 
Decreases peripheral monocytes with 
impaired phagocytosis. 
Reduced elastic recoil and lung 
volumes 
Poor blast transformation of 
lymphocytes  
Reduced diffusion capacity 
Defective C3 opsonic function Occult micro plugging of airways  
 Reduced ventilatory response to 
hyperemia. 
This is adapted from Infections in Diabetes mellitus. (31) 
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WHAT EFFECT INFECTION PRODUCES ON METABOLISM:(33) 
 
 
 The major cause of hyperglycemic crisis is infection.  It is the most common  
cause  for  precipitation of ketocidosis in diabetics and it accounts for 30% of cases.  
Due to increased secretion of counter regulatory hormones such as glucagon, cortisol, 
GH and catecholamines, gluconeogenesis is stimulated and blood glucose levels are 
increased and insulin secretion is inhibited.  This results in relative or absolute insulin 
deficiency.  In NIDDM due to insulin resistance significant hyperglycemia may persist 
as glucose uptake in liver and skeletal muscles is impaired.  The elevation of counter 
regulatory hormones should be dealt with immediately considering condition itself and 
infection too. 
 
The underlying mechanism has still to be determined, but increases circulating cortisol 
concentrations and in certain cytokines, secreted by immune cells in response to 
infection, may contribute amongst the latter are the interleukins and TNF &, which 
impair insulin action by inhibiting the tyrosine kinase activity of the insulin receptor.  
Hence the requirement is to keep blood sugar near normal levels.  
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SPECIFIC INFECTIONS IN DIABETES MELLITUS: 
Incidence of infections in DM: (2) 
 UTI   28.6% 
 TB   20.1% 
 Skin Infection 28.6% 
 
 Bacterial  
 Pneumonia   10.4% 
 Foot infection 10.4% 
 URTI   8.4% 
 PUO   5.8% 
 Cholecystitis  3.2% 
 CSOM  1.3% 
 Others  9.1% 
 
 The above table is the summary of a retrospective study on incidence and pattern 
of infections in diabetes mellitus conducted by Department of Endocrinology, IMS  
Srinagar. From this study it is clearly evident that TB is the third most common 
infection in diabetics next to UTI and skin infection followed by Bacterial pneumonia.   
12 
 
BACTERIAL PNEUMONIA 
 
 Infections with increased frequency may be due to Staphylococcus aureus and 
gram-negative organism such as Klebsiella, E-coli, Enterobacter, Pseudomonas and 
Acinetobacter.  
 
 Infections with possibly increased morbidity and mortality may be due to 
Streptococci, Legionella, Viral infection. Viral infections in diabetic patients are often 
complicated with Bacterial Pneumonia.   
 
 Anaerobic bacteria may cause pneumonia as a result of esophageal disorders 
(motility) disorders & ciliary motility, impaired bronchial and bronchiolar reactivity 
(Clearance mechanism). 
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INFECTIONS WITH INCREASED FREQUENCY: 
 
Staphylococcal Infection: 
 
Staphylococcus is a major pathogen in the etiology of both community acquired and 
nosocomial pneumonia in diabetic patients.  On the basis of a high nasal carriage rate, 
diabetics are though to be at an increased risk of staphylococcal pnemonia.  Upto 30% 
of diabetics are nasal carriers of S.aureus as compared to 11% in normal individuals. 
(34) The rate of nasal carriage of S.aureus is directly related to HBAIC levels (35, 36).  
Pneumonia due to S. aureus may be either primary, following aspiration of organisms 
from upper airway, or secondary to hematogenous spread of distant infection.  S.aureus 
pneumonia typically presents as an actue process with lobar or segmental consolidation, 
no clinical or radiographics features can distinguish from the other types of pneumonia.  
Diabetics are at a risk of developing complications of bacteremia in S. aureus 
pneumonia, with increase in mortality (36). 
 
Gram Negative organisms: 
 
GN aerobes cause approximately 10% - 20% of all community acquired 
pneumonic and 60 – 80% of all nosocomial pneumonia (37). In general, gram negative 
bacteria are acquired by the following three routes: 
14 
- Aspiration of the pathogen from the colonized pharynx 
- Hematogenous spread of extrapulmonary infection (or)  
- Acquisition via contaminated equipment such as contaminated nebuliser. 
 
Although the latter two mechanisms are sometimes encountered, aspiration is the most 
known way of lung infection.  The upper airway colonisation occurs within 24 – 48 
hours of hospitalization even in normal individuals; lowest healthy individuals are 
resistant to upper airway colonization by GN aerobic bacteria (28).  The predisposition 
of diabetics to the development of gram negative aerobic pneumonia is attributed to an 
increased rate of upper airway colonisation with these organisms (38).  The ability of 
GNB to adhere to the upper respiratory epithelium is also increased in diabetic patients.  
Upon adherence, bacteria are aspirated into the lungs, where last defense may be further 
impaired by factors such as coexisting pulmonary edema and impaired phagocytosis.  
Retrograde colonization of the pharynx from the stomach may be an additional factor at 
medical intensive care units (39).  The subsequent risk & aspiration is increased by 
diabetic gastroparesis. (40). 
 
Pulmonary Infections With Increased Mortality and Morbidity: 
Gram-positive cocci such as S.pneumonia are responsible for the majority of 
infections in diabetic patients, followed by agents such as H. influenza (41).  Diabetics  
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may develop a more severe disease due to organisms such as S. Pneumonia, and have 
higher rates of hospitalization and development of complications such as bacteremia. 
Diabetes has been associated with a increased risk of recurrent bacterial pneumonia. 
(42). H. influenza is not more common in diabetics, although it may be more common 
in the elderly in whom type 2 diabetics is also prevalent (43) 
 
Aerobic gram-negative organisms and staphylococcal infections typically are the 
most important causes of nosocomial pneumonia in diabetic patients.  Furthermore, 
approximately 25% of nosocomial infections are polymicrobial.  Bacterial pneumonia 
in diabetic individuals, especially when caused by Klebsiella and Staphylococcus, is 
assoiated with the more severe course of the disease and more frequent need of 
mechanical ventilatory support. (44) 
 
Streptococcal Infection: 
 
 Although diabetics may have a slightly higher rate of carriage of group A 
streptococcus which can cause severe pneumonia it is unclear whether diabetes can be 
separated as a risk factor.  Of all streptococcal infections, group B streptococcal is most 
severe micro organism in diabetic patients. Lung may be the portal of entry.  Diabetes is  
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a risk factor for development of bacteremia in pneumococcal pneumonia resulting in 
mortality.  (45). 
 
Anaerobic Bacteria: 
 Aspiration of oropharyngeal contents, composed of anaerobic bacteria, frequently 
occurs in the normal host but rarely results in pneumonia in the presence of intact 
pulmonary clearance mechanisms.  Although DM is not specifically identified as a risk 
factor for developing pulmonary infections, diabetic patients are probably at risk 
because of altered cough and clearance mechanisms, esophageal disorders and 
depressed mental status (hypoglycemic seizures), which are identified as risk factors for 
developing aspiration pneumonia.  (46). 
 
The most important complications of pneumonia in diabetics are pleural effusion, 
empyema (because of the increased risk of aspiration, esophageal disease, neurologic 
abnormalities) and bacteremia (klebsiella infection is the most common cause of 
septicemia and associated with a high incidence of metastatic infections), which 
increases the mortality twofold in diabetics (46). 
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PULMONARY TUBERCULOSIS: 
The onset of lung tuberculosis is more common in diabetics than in general population.  
Lung TB is a common accompaniment of diabetes and the cause of insulin resistance 
and “brittleness”.  The incidence of diabetes amongst PT patients was much higher 
compared to normal population.  In some parts of the world with still endemic TB, a 
higher than expected proportion of patients with TB have diabetes.  When persons with 
diabetes do not respond in spite of appropriate treatment, they should be screened for 
TB, as weakness, sweating and weight loss are common for both TB and diabetes.  The 
presence of anorexia in a diabetic may point to associated TB (41). 
 
 
Some important points about lung tuberculosis in diabetes: 
 
• The development of lung TB is more common in diabetic individuals than in 
general population. 
• The duration of diabetes has no effect on the occurrence of PT. 
• The incidence of TB is increased in uncontrolled diabetics and in patients with 
severe diabetes requiring high doses of insulin. 
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• The problems in diabetics with lung TB include a severe form and more 
aggressive course of the disease, a higher tendency to destruction and 
cavitation, and more common resistance to ATT.(47) 
• Atypical chest X-ray findings: lower lobe or multiple lobe involvement, 
higher incidence of cavitation, and high incidence of pleural effusion in 
diabetics than in non-diabetics. 
• Complete resolution occurs in patients with HLA A1 and DR. 
• In patients with HLA A2 & DR3, large caseous form of Tuberculosis is 
formed.  
 
Probable reasons for high association of TB and diabetes: 
 
• Hyperglycemia favours the growth, viability and propagation of tubercle 
bacilli. 
• Disturbance of electrolyte balance and local tissue acidosis favour infection. 
• Impaired phagocytosis and impaired cellular immunity in persons with 
diabetes allows for the spread of the disease over neutralizing antibodies in 
bronchial secretions. 
• Lower resistance due to vascular damage to lung tissue. 
• Disordered nutritional balance. 
  
 
 
 
 
 
 
 
METHODOLOGY 
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MATERIALS AND METHODS 
 
 Known diabetic patients/cases recently diagnosed to have DM  during the course 
of hospital stay who had features of pleuropulmonary infections clinically in the form 
of fever, cough, pleuritic chest pain with or without hemoptysis with radiological 
features supporting the same,between January 2006 to June 2007  were evaluated for 
inclusion in this study. 
 
 In all these patients, a detailed history was taken and a thorough clinical 
examination was done as well.  These cases were then subjected to investigations after 
getting informed consent.  Basic hematological and biochemical investigations included 
Complete Hemogram with Total count and Differential count, Fasting and Post Prandial 
Blood sugar, Blood Urea, Serum Creatinine, Serum Electrolytes and Liver function 
tests.  In patients with impaired glucose tolerance, Oral glucose tolerance testing was 
done and the following criteria was used to diagnose diabetes mellitus.   
 
 
 
 
 
 
 
 
 
Categories of Hyperglycemic according to various plasma glucose concentrations 
(12, 13,14) 
Fasting plasma glucose 
Normal  a Impaired  a Diabetes 
 
2 hr post load plasma 
glucose level 
< 100mgldl 100-125mgldl > 126mgldl Not done 
<140mgldl 
(7.8mmo1/L) 
Normal  b IFG Diabetes “Normal” 
140-199 mgldl 
(7.8-11.0mmo1/L) 
IGT  b IFG/IGT  c Diabetes IGT 
> 200mgldl 
(> 11.1mmo1L) 
Diabetes  b Diabetes  b Diabetes Diabetes 
Not done “Normal” IFG Diabetes Unknown 
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a. The 1987 ADA and 1999 wHO recommendations for fasting plasma glucose 
valves were as follows: normal 110mgldl; impaired 110-125mgldl; The values 
listed in the table reflect the most recent 2003 ADA expert committee 
recommendations. 
 
b. These categories are identifiable only if OGTT is performed  
 
c. This category is currently classified by ADA recommendations as IFG and IGT 
and by WHO  as IGT. 
 
 Patients in whom diabetes mellitus was confirmed by the above tests ,were 
included in this study and subjected to appropriate investigations as follows: 
 
 From all such patients, the following samples were submitted for microbial 
analysis.   
a) Sputum 
b) Blood 
c) Pleural fluid (if  present ) 
d) Bronchial wash (in selected cases) 
Cases with clinical, radiological features, sputum for AFB analysis 
negative for PT were evaluated for pyogenic infections. Blood, sputum, 
pleural fluid (if present) were submitted for gram stain, NT culture, fungal 
smear and fungal culture and these patients were started on appropriate 
parenteral antibiotics.  They were followed up with chest radiographs.  
Patients not responding to antibiotics and those in whom the above 
samples did not contribute to diagnosis were subjected to Bronchoscopic  
assessment after computerized tomogram evaluation of the chest.  
Bronchial wash was taken from the involved segments as assessed by CT 
chest and sent for detailed microbial analysis which included AFB smear, 
Gram stain, NT culture, Fungal smear and Fungal culture and antibiotic 
therapy was reinstituted as per the results.  In patients with features 
suggestive of  pneumonia , severity was assessed using CURB 65 score.
CURB 65 SCORING SYSTEM: 
      Confusion 
 
    Blood Urea Nitrogen > 20 MG/DL 
 
    Respiratory Rate > 20 / min 
 
    Low Blood Pressure SBP < 90 MM HG 
 
    Age > 65 yrs 
 
RISK STRATIFICATION USING CURB 65 SCORE:( 56 ) 
 
  GROUP 1: SCORE 0-1: LOW MORTALITY (1.5%) 
 
 
  GROUP 2:  SCORE 2:  INTERMEDIATE  MORTALITY  (9.2%)  
 
 
  GROUP 3:SCORE 3 OR MORE: HIGH MORTALITY (22%) 
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The following diagnostic algorithm was followed for  diagnosis of  Pulmonary TB.(15) 
cough more than 3 weeks 
| 
3 Sputum Smear 
 
 |        | 
  2 or 3 Positive            3 Negative 
                | 
              Antibiotics 10-14 days 
                | 
               Cough persists 
Sputum Smear Positive           | 
 |           Rpt 3 Sputum Smear  
|  |            | 
   No Prior      H/O Prior           1 Positive     |   |  
     ATT  ATT         |       Negative  2 or 3 Positive 
 |  |     X-Ray       | 
New Case Retreatment Case       |         Sputum Positive TB 
  |  |    |       |        (ATT) 
Cat I ATT Cat II ATT     Suggestive  Negative for    
           of TB      TB         X-Ray 
       |      | 
            ATT     |  | 
             Negative      Suggestive of TB 
              for TB  | 
      CAT III  ATT 
        Non TB   
25 
 
 
 Sputum smear negative cases whose clinical and radiological features 
were not definitely conclusive of PT were subjected for Bronchoscopy and 
Bronchial wash was sent for AFB smears, AFB culture, Gram stain, NT 
culture, fungal smear and culture.  After ruling out pyogenic/ fungal 
infections, these patients were started an ATT and followed up after 2 
months  with repeat chest radiographs and Bronchial wash AFB culture 
results.  Those patients with clinical/ radiological improvement at the end of 
2 months were continued on the same line of management. Those in whom 
these was no adequate response to ATT /  Bronchial wash AFB culture  
Negative were excluded from this study, as there was a high possibility of 
non-infections causes  including  malignancy  in  such  cases. 
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TREATMENT ALGORITHM FOR POSSIBLE TB INFECTION (49) 
       
(SPUTUM FOR AFB SMEAR NEGATIVE) 
 
 
At risk patient 
Abnormal CXR 
Negative smear 
| 
High clinical suspicion for PT 
Not responding to Antibiotics 
| 
Start ATT 
Give sputum/ Bronchial wash for AFB culture 
| 
        |   |     | 
    Initial         Initial     Initial culture 
    Culture       Culture                  Negative 
    Positive      Negative   Radiologic/ Symptomatic  
       |  No change in CXR  improvement 
       Continue ATT  |     | 
        TB unlikely           Culture negative PTB  
       |     | 
          Excluded from the study   Continue ATT. 
27 
 
This section deals with the method of evaluation of pleural diseases.  
Thoracentesis was done in all patients with pleural effusion and pleural fluid 
biochemical, cytological, microbial analysis was done.  Pleural biopsy was done in case 
of exudative pleural effusion wherein bacterial/ fungal infection was ruled out and after 
ruling out malignancy, these patients were started on ATT.  Sputum AFB smear was 
done for cases of pyothorax  with underlying parenchymal disease.  If Sputum AFB/ 
pleural fluid AFB was positive then patient was started on ATT and ICD was done. In  
sputum /P1 fluid AFB negative cases, CT chest was done after ICD insertion.  If the 
nature of the underlying  parenchymal disease was in favour of Tuberculosis these 
patients were started on ATT and those with CT features suggestive of pyogenic 
infection (in the form of consolidation/ lung abscess) were started on parenteral 
antibiotics and followed up with serial chest radiographs. 
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EXCLUSION CRITERIA: 
 
 Patients with age < 15 yrs; secondary causes for hyperglycemia (like drug 
induced, pancreatic pathology, other endocrine disorders); other associated 
immunodeficiency states like retroviral disease, renal/ hepatic failure; patients on 
immunosuppressive drugs; diabetic patients with endobronchial mass lesion causing 
obstructive pneumonia/ lung abscess; patients with transudative pleural effusion were 
all excluded from this study. 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
results 
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Table 1: INCIDENCE OF PLEURO PULMONARY 
INFECTIONS IN DM 
 
TYPES NO. OF CASES 
OF NON TB 
INFECTIONS 
NO. OF CASES 
OF TB 
PERCENTAGE
Impaired Glucose 
Tolerance 
 
Type 1 DM 
 
Type 2 DM 
 
- 
 
3  
 
40 
 
5  
 
4  
 
54  
 
5% 
 
7% 
 
88% 
Total 43 63 100% 
 
 
 Majority of pleuropulmonary infections occurs in Type 2 DM accounting for 
about 88% (n=94) and only 7 cases out of 106 cases were Type 1 diabetics contributing 
to around 7%. Among patients with Tuberculosis ,8%  had impaired glucose 
Tolerance(19). 
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  Table 2: DISTRIBUTION OF PATIENTS BY TIME 
INTERVAL BETWEEN DIAGNOSIS OF DM & 
PLEUROPULMONARY INFECTIONS. 
 
Time Interval 
between Diagnosis 
of DM and 
Pleuropulmonary 
Infections 
Number of 
Cases due to 
Non TB 
Infection 
Number of 
Cases due to TB
Percentage 
Synchronous  
< 1 yr. 
1 – 5 yrs 
6 – 10 yrs 
> 10 yrs 
15 
8 
10 
8 
2 
25 
13 
15 
7 
3 
38 
20 
23 
14 
5 
Total 43 63 100 
 
 From this table it is evident that most of the pleuropulmonary infections occur 
within the first 5 years of diagnosis of diabetes mellitus, unlike microvascular 
complications which has a long latency period. 
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Table: 3 DISTRIBUTION OF CASES BY AGE AND SEX 
 
 
Non 
Tuberculous 
Infections 
TuberculosisAge in 
years 
Male Female 
Percentage 
of NT 
Infections
Male female
Percentage 
of TB
< 25 yrs. 
25-34 yrs 
35-44 yrs 
45-54 yrs 
55-64 yrs 
> 65 yrs 
2 
1 
9 
10 
2 
1 
1 
1 
7 
6 
2 
1 
3%
2%
15%
15%
4%
2%
2
3
14
12
6
2
2
2
7
8
4
1
4%
4%
20%
19%
9%
3%
Total 25 18 41% 39 24 59%
Tuberculosis: 
 Male: 39 (62%); Female: 24 (38%), Total: 63 
 
Non Tuberculosis Infection: 
 Male: 25 (58%); Female: 18 (42%), Total: 43 
 
Majority of these infections i.e. about 69% of cases are between 35 – 54 years(17) and 
there is a slight male preponderance with male: female ratio of 3:2. 
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Table 4: ETIOLOGICAL CLASSIFICATION OF 
PLEUROPULMONARY INFECTIONS IN DIABETICS 
 
Etiology Total Number of 
Cases 
Percentage 
Bacterial Infections 40 38% 
Strep. Pneumonia 
Staph. Aureus  
H. Influenza  
Pseudomonas 
Klebsiella 
Nocardia 
GPC + GNR,MIXED 
Not Identified 
2(5%) 
9(23%) 
2(5%) 
8(20%) 
7(17%) 
1(2%) 
4(10%) 
7(18%) 
 
Protozoal 3 3% 
Amebiasis 3  
Tuberculosis 63 59% 
Pleural 
Parenchymal 
Pleural & Parenchymal 
5 (8%) 
45 (71%) 
13 (21%) 
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 RIGHT U/L CONSOLIDATION 
 
KLEBSIELLA PNEUMONIA                                   
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RIGHT U/L CAVITATING CONSOLIDATION 
 
 
 
STAPHYLOCOCCAL PNEUMONIA 
 
 
 
37 
38 
 
 
 
 
 
NOCARDIOSIS 
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Table 5: RADIOLOGICAL MANIFESTATIONS OF PTB  
 
IN DM 
 
 
NUMBER OF PATIENTS RADIOLOGICAL 
PATTERN MALE FEMALE 
PERCENTAGE 
U/L Cavitary disease 6 3 16% 
U/L Nodular opacity 6 3 16% 
B/L extensive lesion 17 6 39% 
Lower Lung field TB 5 9 24% 
Miliary TB 2 1 5% 
Total 36 22 100% 
 
 
 This table shows the chest roentgenographic changes of PTB in diabetics. B/L 
extensive lesion with multiple patterns (cavitary and exudative nodular opacities) is 
common in diabetics with poor glycemic control. Lower lung field TB accounted for 
about 24% of radiological manifestation.  
 
 
 
 
 
RIGHT U/L PTB 
 
 
   B/L EXTENSIVE PTB 
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MILIARY TUBERCULOSIS 
 
 
   LOWER LUNG FIELD TB 
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TABLE 6: METHODS OF DIAGNOSIS OF   
 
 PULMONARY TUBERCULOSIS 
 
 
Total Number of Pulmonary Tuberculosis:  58 
 
 
Total Number of Pleural Tuberculosis:    5  
 
 
 
Sputum Smear Sputum/ Bronchial Wash 
AFB Culture 
Number of 
Case 
Percentage 
Positive 
Negative 
Negative 
Not done 
Positive 
Negative 
30 
7 
21 
51.7% 
12% 
36.2% 
 
 
 Sputum smear was positive in about 51% of PTB cases (n=30) and  
 
diagnosis was established by AFB culture in 12% of cases.  In 36% of cases  
 
diagnosis was made on radiological grounds and therapeutic response  
 
 to a trial of ATT. 
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Table 7:  RADIOLOGICAL MANIFESTATIONS OF  
BACTERIAL INFECTIONS. 
Pattern Number of cases Percentage 
Consolidation 
Lung Abscess 
Bronchiectasis 
Diffuse Parenchymal/ 
Interstitial Opacities 
15 
12 
7 
6 
38% 
30% 
17% 
15% 
Total 40 100% 
 
 Among the radiological patterns of Pulmonary lesion caused by Bacterial 
infections, consolidation (38%) and Lung Abscess (30%) accounted for the majority. 
Out of the 7 cases of bronchiectasis, interestingly 3 cases were Type 1 Diabetics 
accounting for about 40 % and in all the 3 patients ,cystic fibrosis was ruled out by 
sweat chloride test. 
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Table 8: PLEURAL MANIFESTATIONS IN     DIABETES 
MELLITUS 
 
Microbial 
Agent 
Pleural Disease No 
underlying 
Parenchymal 
disease 
Underlying 
Parenchymal 
disease  
Non Tuberculosis 
Infection 
Parapneumonic 
effusion 
Empyema  
 
- Pyogenic 
 
- Hepatopleuro 
pulmonary amebiasis 
Nil 
 
Nil 
 
Nil 
 
 
Nil 
4 
 
8 
 
(5) 
 
 
(3) 
Tuberculosis Pleural Effusion 
 
Pneumothorax 
 
Hydro/ 
Pyopneumothorax  
5 
 
Nil 
 
 
Nil 
1 
 
2 
 
 
10 
 
 Out of 106 patients analysed, 30 patients had pleural involvement,  accounting 
for about 28%.  Among 63 patients with TB, pleural disease was observed in 
approximately 30% (n=18) of patients. Hepatopleuropulmonary amebiasis contributed 
to 10% of pleural diseases in diabetics. 
 
 
 
47 
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HEPATOPLEUROPULMONARY AMEBIASIS 
 
 
 
 
 
AMEBIC LIVER ABSCESS -CT 
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DISCUSSION 
 
 A total number of 106 cases were analysed from Jan 2006 to June 2007. Of these 
106 cases, 88% of the cases were Type 2 diabetics and 7% of the cases were grouped 
under Type 1 DM as shown in Table 1.  This apparent increase in the incidence of 
pleuropulmonary infections in NIDDM may be due to the fact that Type 2 DM 
constitutes to about 90 to 95% of DM (3) and Type 1 DM sums only up to about 10%. 
 
 The association of PTB with Impaired glucose tolerance varies between 2 to 41% 
as reported by various research workers (32).  As mentioned by M.M. Singh et al (4) 
apart from TB infection per se leading to alteration in glucose tolerance, the effect of 
other factors like fever, bed rest, malnutrition and drugs on glucose tolerance might 
have contributed to such high association between PTB and IGT in those studies. In our 
study the association of PTB with IGT was about 8%. 
According to Ezung T. et al, duration of diabetes did not correlate well with 
prevalence of pulmonary infections unlike vascular complications  
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(17). From Table 2, it is evident that in a developing country like India where people 
are reluctant to seek early medical care, a high proportion of  
patients are found to be diabetics incidentally at the time of diagnosis of pulmonary 
infection.  This emphasizes the necessity of screening all patients with pulmonary 
infections irrespective of the etiology (TB or Non TB infection) for diabetes mellitus.  
LUNG is a “Mirror” reflecting most of the systemic disorders and Diabetes Mellitus is 
“No Exception to this Rule”.  
 
Peak incidence of infections i.e. around 69% occurred between 3rd decade to 5th 
decade in synchronous with the study on influence of DM on manifestation and 
treatment outcome of PT published in International Journal of TB and lung Diseases 
(50).  Though pleuropulmonary infections are not very common in elderly age group in 
our study, they tend to occur with increased severity .   
 
In coherence with the study conducted by Feleke. Y. and Abdul Kadir et al (8) 
wherein the prevalence of TB among males was 59% and females 41%, in our study, 
the occurence of Diabetic Tuberculosis in males and females was 62% and 38% 
respectively.  The occurence of Non-Tuberculous infection in men was 58% and in 
women was 42% close to the observation  
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of Miquel Falguere et al wherein male and female incidence of CAP in DM was 62% 
and 38% (1). Male preponderance is seen between the age group 35 – 54 yrs but in 
extremes of age group, sex predilection is lost and infections occur with more or less 
the same frequency in both sexes. 
Regarding non TB infections in diabetics, about 60% of cases are due to Staph. 
aureus, Klebsiella and Pseudomonas and similar patters of non tuberculous infections 
among diabetics were reported by Koziel et al (11) from Harvard Medical School, 
Boston.  However, due to lack of adequate facilities for detection of atypical, anaerobic 
organisms, the definitive etiological agent could not be identified in 28% of the cases in 
our study.  Further rare infections due to Nocardia and Hepatopleuropulmonary 
Amebiasis were reported in a minority group.  
 
From table 7, it is evident that consolidation and Lung Abscess were the major pattern 
of Lung infections caused by Bacteria. Analysis of pneumonia in diabetics discloses 
that around 30%of pneumonia is due to virulent Gram Negative organisms like 
Klebsiella and Pseudomonas .25% of pneumonia is due to gram positive organisms like 
Streptococcus Pneumonia & Staphylococcus aureus .Similar to the results of Etiology 
& Outcome of Pneumonia in DM by Miquel Falguera et al(1),where microbial agent 
was not identified in 30%of cases, etiology was not identifiable in 33% of pneumonia in 
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diabetics in our study also .  On risk stratification of diabetics with CAP, majority of 
patients (about 60%) with poor glycemic control, were grouped into intermediate and 
high risk group according to CURB 65 scoring system  
detailed in the previous section of methodology which highlights that infections tend to 
occur aggressively in uncontrolled hyperglycemic states. 
In around one third of Lung Abscess cases ,organism  was not isolated by aerobic 
culture although sputum Gram stain revealed Gram Positive Cocci and Gram Negative 
Bacilli, which could be an indirect evidence for anaerobic etiology .In our study, 
Staphylococcus contributes to about 30% of lung abscess as against 23.3% reported by 
Khakar et al(54).As mentioned earlier oropharyngeal colonization with Staphylococcus 
aureus is high in diabetics (36) and microaspiration of theses organisms leads to 
frequent suppurative lung infections in these patients. Klebsiella and Pseudomonas 
contributes to the rest in our patients and infection with GNB carries high risk for 
mortality. 
 In our study, 28% patients with Empyema had Non Tuberculous Bacterial 
infection. Among the pyogenic organisms isolated, Staphylococcus, Klebsiella  and 
Pneumococcus  contributed to 20 % each. 40% were due to Polymicrobial infection in 
contrast to 20% as observed by Brook and Frazier et al (21). 18% of  PleuroPulmonary 
suppuration was due to Hepatopleuropulmonary  
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Amoebiasis.55% of  Empyema in diabetics were due to Tuberculosis  in  this study in 
corroboration with the studies conducted by Acharya Preetam et al (22) & Volshyn Iam 
(10). 
Most common causes of infective exacerbation in diabetics with Bronchiectasis 
were Pseudomonas and Staphylococcus similar to the observation in non diabetics as 
well. Interesting observation was that 3 patients of IDDM had Bronchiectasis and this 
was the only radiological  pattern of pyogenic infections observed in IDDM. This 
observation may require insight into the impairment of local defense mechanisms in 
IDDM which makes them prone for recurrent respiratory infections and Bronchiectasis. 
  
 As expected in a high endemic country for Tuberculosis like India, Tuberculosis 
accounts for 60% of the pleuropulmonary infections in diabetics.  Pleural involvement 
in Tuberculosis was seen in about 1/3 rd of cases as supported by studies on coexistence 
of PTB and DM by Wilcke et al (55) and Hussain et al (29). 
 There are many studies on roentgenographic findings of PTB in DM to quote a 
few are in references (5,23).Sosman and steidl et al defines “diabetic Tuberculosis” has 
a special radiological pattern consisting of  
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confluent, cavitary, wedge shaped lesion extending from the hilum towards the 
periphery, predominantly in lower zone to the extent of around 20%  
(30). Multiple lobe involvement was the predominant radiological presenting pattern of 
TB accounting for about 39% (52), similar to the conclusion from a study on pulmonary 
TB in diabetics done by Joseph Morris et al in 1992 (51).  Lower lung field TB 
accounted for 25% of the cases compared to 20% of LLFTB reported in the above 
study.  But there are conflicting results as far as Lower lung field TB in diabetics is 
concerned and reported incidence varies from 0.2 to 18% (7).  Miliary TB was reported 
in 5% of Tuberculosis patients with poor glycemic control. 
 
 Analysis of Table 6 shows that 52% of the Tuberculosis cases were diagnosed by 
Sputum Smear microscopy.  Sputum/ Bronchial wash AFB culture contributed to 
diagnosis only in 12% of the cases and in the rest of the cases ATT was started based on 
clinical and radiological grounds.  Similar results were observed by Prasad et al in 
which sputum AFB culture alone attributed to diagnosis only in 10% (52).  Pointers 
towards diagnosis of PTB in sputum smear/ culture negative cases were poor glycemic 
control, H/o definitive contact with an infectious case, low BMI and characteristic 
radiological involvement & therapeutic response to ATT. 
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As mentioned earlier, pleural involvement in TB is seen in 30% of the patients 
and majority of these (around 70%) were associated with underlying parenchymal 
disease.All cases of Tuberculous Empyema were associated with underlying 
parenchymal disease in our  study and Bacteriological confirmation was possible in 
70% of the cases and similar findings were reported by Acharya Preetam et al in his 
study(22) .Empyema due to TB and non Tuberculous etiology required protracted 
treatment with parenteral antibiotics/ ATT and intercostal drainage.  Despite such a 
long duration of treatment, persistence of pleural thickening resulting in trapped lung 
was much higher. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSIONS 
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CONCLUSIONS 
  
Following were the inference drawn from this study: 
 
1. The peak incidence of pleuropulmonary infections in this study were in the 
age group of third decade to fifth decade.  Thus it would be prudent to screen all 
patients in this age group presenting with respiratory infection, for diabetes 
mellitus(18). 
 
2. Majority of pleuropulmonary infections of Non Tuberculous etiology were 
due to Gram Positive Organisms – Staphylococcus pneumonia and Streptococcus 
pneumonia (25%) and Gram Negative Organisms – Pseudomonas, Klebsiella, H. 
Influenza (40%).  
3. The application of this knowledge is very important in tailoring early 
appropriate antibiotic therapy for diabetic patients where culture facilities are not 
available as even a short delay in initiating treatment may lead to rapid progression of 
infection leading to increased mortality and morbidity. 
5.  Risk stratification of Bacterial pneumonia in diabetes using CURB 65 
scoring system shows that around 60% of patients were categorized under group 2 and 
group 3 suggesting that bacterial infections  
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tend to be more aggressive in diabetics especially those with uncontrolled 
hyperglycemia. 
 
 
6. Pulmonary Tuberculosis tends to occur with increased severity in diabetics 
as evidenced by the occurrence of B/L extensive lesion with multiple radiological 
patterns in around 40% of cases in our study.  Further to support this, bacillary loads 
were high among diabetics with poor glycemic control (as assessed by increased 
grading of sputum positivity). 
 
7. Association of pulmonary infections with pleural involvement occurs in 
about 30% of diabetics demanding protracted course of antibiotics and ICD for a 
duration of about 6 – 8 weeks and increases the morbidity in such patients. 
 
8. From the analysis of mortality among patients with pleuropulmonary 
infections and DM, predictors of mortality were a combination of advancing age, poor 
glycemic control, chronic debilitation with low BMI (especially among PTB patients), 
Diabetic keto Acidosis, multilobar involvement and bacteremia. Hence cases with the 
above mentioned risk factors require special attention and aggressive treatment of 
infection. 
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SUGGESTIONS 
 
 
Diabetes and pulmonary infection is a “deadly duo”, one fueling the progression of the 
other.  Prevention is better than cure-though sounds old, still holds good for most of the 
infectious epidemics.  The following suggestions may be tried to prevent the double 
trouble of DM and pulmonary infections from sweeping our country. 
 
1. Emphasizing the importance of adherence to treatment among diabetics 
and maintenance of blood sugar levels to near euglycemic state may in a long run 
decrease the incidence of respiratory infections in them. 
 
2. Patient education regarding early approach to medical care for respiratory 
symptoms (which are neglected as “Common cold” very often) may decrease the 
occurrence of severe forms of infections. 
 
3. As PTB remains as the single most common cause of pulmonary infections 
in diabetics, lowering the threshold for diagnosing PTB and early institution of ATT 
may limit extensive forms of the disease. 
 
4. Trials regarding efficacy of vaccines in controlling the incidence of 
infections among high-risk diabetics (like those with uncontrolled hyperglycemia, 
tendency for “brittleness”, elderly age group, IDDM) may be encouraged. 
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SHORTCOMINGS OF THE STUDY: 
 
 
Due to the lack of adequate facilities for detailed microbial analysis 
 
 
including viral studies ,immunological studies for detecting  atypical  pathogens and  
 
 
anaerobic culture methods, definitive etiological agent could not be identified in 28%   
 
 
of  Bacterial infections . 
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ABBREVIATIONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
ABBREVIATIONS 
 
 
 
DM   - Diabetes Mellitus 
 
IDDM  - Insulin Dependant Diabetes Mellitus 
     (or) 
    Type 1 DM 
 
NIDDM  - Non Insulin Dependant Diabetes Mellitus 
     (or) 
    Type 2 DM 
 
ADA   - American Diabetes Association 
 
IFG   - Impaired Fasting Glucose 
 
IGT   - Impaired Glucose Tolerance 
 
OGTT  - Oral Glucose Tolerance Test 
 
WHO   - World Health Organisation 
 
ATT   - Anti Tuberculous Treatment 
 
RNTCP  - Revised National TB Control Programme 
 
NADPH  - Nicotinamide  Adenine Dinucleotide phosphate. 
 
HMP   - Hexose Mono Phosphate Shunt Pathway 
 
TNF ∝  - Tumor Necrosis factor – Alpha 
 
GNB   - Gram Negative Bacilli 
 
GPC   - Gram Positive Cocci 
 
PTB   - Pulmonary Tuberculosis 
 
LLFTB  - Lower Lung Field Tuberculosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MASTER CHART FOR PLEURAL /PULMONARY TUBERCULOSIS IN DM(1) 
 
 
 
 
Sl. 
No. Age Sex 
Time 
Interval Radiological
Blood 
Sugar 
Sputum 
AFB Sputum/   
        Pattern Level Smear Bronchial wash Diagnosis
              AFB culture    
                  
1 A Y a 2q I NEG   N 
2 A Y c 2t II 1POS   N 
3 A X b 2t II 1 POS   N 
4 A X b 2r & 1g III 2 POS   N 
5 B Y c 2q I  3 POS   N 
6 B Y c 2t II NEG   N 
7 B Y b 1e II NEG   N 
8 B X c 2t III NEG   N 
9 B X b 2r  II NEG   N 
10 C Y b 2t III  SC POS   N 
11 C Y c 2u IV NEG   N 
12 C Y c 2q & 1g II NEG   N 
13 C Y a 2q I 2 POS   N 
14 C Y b 2s & 1e III NEG   N 
15 C Y a 2t II NEG   N 
16 C Y a 2s & 1f III NEG   N 
17 C Y a 2r I NEG   N 
18 C Y b 2r & 1g II NEG   N 
19 C Y a 1e III NEG   N 
20 C Y a 2s II 3 POS   O 
21 C Y a 2s III 2 POS   N 
22 C Y a 2s III NEG   N 
23 C Y a 2s II 3 POS   O 
24 C X c 2t II NEG   N 
25 C X c 2s & 1f III 3 POS   N 
26 C X b 2t II NEG S Positive N 
27 C X d 2t II SC POS   N 
28 C X b 2q I 2 POS   O 
29 C X a 1e II NEG   N 
30 C X a 2r II NEG   N 
31 D Y a 2t II NEG   N 
32 D Y c 2q  II NEG B Positive N 
33 D Y d 2s III 3 POS   M 
34 D Y c 2r II NEG   N 
35 D Y b 2q & 1g III NEG   N 
36 D Y a 2s II 3 POS   O 
37 D Y d 2r II 3 POS   M 
38 D Y a 2r III NEG B Positive N 
39 D Y a 1e II NEG   N 
40 D Y c 2s & 1g III NEG   N 
41 D Y a 2s II 3  POS   N 
42 D Y a 2s III 1 POS   N 
43 D X d 2s & 1g III 3 POS   N 
44 D X b 2q II SC POS   M 
45 D X a 2t II NEG   N 
46 D X c 2s III 2 POS   O 
47 D X a 2t II NEG B Positive N 
48 D X a 2t II 2 POS   N 
49 D X a 1e II NEG   N 
50 D X e 2u III NEG   N 
51 E Y e 2s II 1 POS   M 
52 E Y c 2s III 1 POS   O 
53 E Y b 2s & 1g IV 3 POS   N 
54 E Y a 2r II NEG B Positive N 
55 E Y d 2s & 1g II 2 POS   N 
56 E Y a 2s III POS   O 
57 E X c 2s & 1g III 3 POS   N 
58 E X d 2s II 1 POS   O 
59 E X b 2q II NEG B Positive N 
60 E X a 2t II NEG B Positive N 
61 F Y e 2s & 1g III 1 POS   N 
62 F Y d 2u III NEG   N 
63 F X c 2s II 3 POS   O 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MASTER CHART FOR NON TUBERCULOUS 
PULMONARY INFECTIONS IN DM (2) 
 
 
 
           SPUTUM/BRONCHIAL   
SL 
NO AGE  SEX TIME  BLOOD RADIOLOGICAL 
WASH/PL FLUID 
/BLOOD CURB 
      INTERVAL SUGAR PATTERN 
GRAM STAIN & 
CULTURE SCORE 
                
1 A Y c p 3 Pseudomonas   
2 A Y b r 3 Staphylococcus   
3 A X d q 3 Pseudomonas   
4 B Y a r 1F Pneumococcus I 
5 B X b q 1F Staphylococcus II 
6 C Y a q 1 Klebsiella II 
7 C Y b q 1 Klebsiella I 
8 C Y a r 1 Pseudomonas I 
9 C Y c r 2E GPC & GNB   
10 C Y a q 2 Staphylococcus   
11 C Y a q 2 Klebsiella   
12 C Y c s 5     
13 C Y b q 4 Not identified III 
14 C Y c q 4 Not identified II 
15 C X a q 1 H.Influenza I 
16 C X c r 1E Pneumococcus III 
17 C X b r 3 Klebsiella   
18 C X c q 2 GPC & GNB   
19 C X a q 2 Staphylococcus   
20 C X c q 4 Not identified I 
21 C X b r 4F Not identified II 
22 D Y a q 1 Staphylococcus II 
23 D Y a r 1E Klebsiella III 
24 D Y d p 3 Pseudomonas   
25 D Y c r 3 Staphylococcus   
26 D Y d r 2 Staphylococcus   
27 D Y d r 2 Klebsiella   
28 D Y c q 2 Pseudomonas   
29 D Y e r 5     
30 D Y a r 5     
31 D Y d s 4 Nocardia III 
32 D X b q 1E Staphylococcus I 
33 D X a q 1 Not identified II 
34 D X c r 3 Pseudomonas   
35 D X a q 2 Staphylococcus   
36 D X d q 2 Pseudomonas   
37 D X b q 4 Not identified I 
38 E Y d r 1F Klebsiella II 
39 E Y a q 1 Not identified I 
40 E X a q 1 H.influenza I 
41 E X e r 2E GPC & GNB   
42 F Y b q 1 Pseudomonas III 
43 F X a r 2 GPC & GNB   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
KEY TO MASTER CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 KEY TO MASTER CHART (1) 
 
 
AGE INTERVAL 
A- <25    YRS 
   B- 25-34 YRS 
   C- 35-44 YRS 
   D- 45-54 YRS 
   E- 55-64 YRS 
   F- >65    YRS 
 
SEX 
   X- FEMALE 
     Y- MALE   
 
  TIME INTERVAL BETWEEN DIAGNOSIS OF PT &DM: 
 
     a- SYNCHRONOUS 
     b- < 1  YEAR 
     c- 1-5  YEARS 
     d- 6-10  YEARS 
     e- >10 YEARS 
 
   
 
 
RADIOLOGICAL PATTERN: 
     1- PLEURAL 
     2- PARENCHYMAL 
     q- U/L CAVITY 
     r- U/L NODULAR OPACITY 
     s- B/L EXTENSIVE LESION 
     t- LOWER LUNG FIELD TB 
     u- MILIARY TB 
     e- PLEURAL EFFUSION 
     f- PNEUMOTHORAX 
     g- PYO/HYDROPNEUMOTHORAX 
 
  BLOOD SUGAR: 
     I- 140-200 MG/DL 
     II- 201-300 MG/DL 
     III- 301-400 MG/DL 
     1V- >400 MG/DL 
 
  DIAGNOSIS: 
     N-NEW CASE(79%) 
     M-MDR TB(6%) 
     O-RETREATMENT CASE(15%) 
   
  DEATH 
    
  
  
TYPE I 
DM 
 
 
 
  
KEY TO MASTER CHART (2) 
 
AGE INTERVAL 
A- <25    YRS 
   B- 25-34 YRS 
   C- 35-44 YRS 
   D- 45-54 YRS 
   E- 55-64 YRS 
   F- >65    YRS 
SEX 
   X- FEMALE 
Y- MALE  
 
TIME  INTERVAL BETWEEN DIAGNOSIS OF NON TUBERCULOUS 
INFECTION & DM: 
     a- SYNCHRONOUS 
     b- < 1  YEAR 
     c- 1-5  YEARS 
     d- 6-10  YEARS 
     e- >10 YEARS 
 
 
 
 
 
 
RADIOLOGICAL PATTERN: 
 
   1- CONSOLIDATION 
   2- LUNG ABSCESS 
   3- BRONCHIECTASIS 
  4- DIFFUSEPARENCHYMALOPACITY     
5- HEPATOPULMONARY AMEBIASIS 
  E- EMPYEMA 
  F- PARAPNEUMONIC EFFUSION. 
  
BLOOD SUGAR LEVEL:  
     
     
   p- 140-200 MG/DL 
   q- 201-300 MG/DL 
   r- 301-400 MG/DL 
   s- >400 MG/DL 
 
  DEATH 
    
  
  
TYPE I 
DM 
 
 
 
 
 
 
 
